WallStreetZenWallStreetZen

NASDAQ: BRTX
Biorestorative Therapies Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their BRTX stock forecasts and price targets.

Forecast return on equity

Is BRTX forecast to generate an efficient return?

Forecast return on assets

Is BRTX forecast to generate an efficient return on assets?

BRTX revenue forecast

What is BRTX's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$120.0k-17.7%
Avg 2 year Forecast
$120.0k-17.7%
Avg 3 year Forecast
$120.0k-17.7%
BRTX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

BRTX revenue growth forecast

How is BRTX forecast to perform vs Biotechnology companies and vs the US market?
Company
-6.29%
Industry
39.26%
Market
10.55%
BRTX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
BRTX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

BRTX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
BRTX$1.32N/AN/A
GRTX$0.16N/AN/A
VIRI$0.48N/AN/A
ASLN$0.54$9.50+1,659.26%Strong Buy
CANF$2.28$18.00+689.47%Buy

Biorestorative Therapies Stock Forecast FAQ

What is BRTX's revenue growth forecast for 2024-2026?

(NASDAQ: BRTX) Biorestorative Therapies's forecast annual revenue growth rate of -6.29% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 39.26%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.55%.

Biorestorative Therapies's revenue in 2024 is $145,800.On average, 1 Wall Street analysts forecast BRTX's revenue for 2024 to be $812,390, with the lowest BRTX revenue forecast at $812,390, and the highest BRTX revenue forecast at $812,390. On average, 1 Wall Street analysts forecast BRTX's revenue for 2025 to be $812,390, with the lowest BRTX revenue forecast at $812,390, and the highest BRTX revenue forecast at $812,390.

In 2026, BRTX is forecast to generate $812,390 in revenue, with the lowest revenue forecast at $812,390 and the highest revenue forecast at $812,390.

If you're new to stock investing, here's how to buy Biorestorative Therapies stock.

What is BRTX's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: BRTX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is BRTX's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: BRTX) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.